首页> 外国专利> ORAL DRUG FOR ETERNAL YOUTH AND IMMORTALITY PREVENTING AGING INFLAMMATION BASED ON TELOMERE REJUVENATION CAUSED BY REDIFFERENTIATED T CELL OF HUMAN IPS

ORAL DRUG FOR ETERNAL YOUTH AND IMMORTALITY PREVENTING AGING INFLAMMATION BASED ON TELOMERE REJUVENATION CAUSED BY REDIFFERENTIATED T CELL OF HUMAN IPS

机译:基于人类IPS减毒T细胞再生的端粒再生的口服药物预防外部年轻化和不孕

摘要

PROBLEM TO BE SOLVED: To perfect eternal youth and immortality by making an improved version 4 of a drug for eternal youth and immortality, and applying latest science.SOLUTION: Eternal youth and immortality is achieved by extending a telomere by the action of T cell redifferentiation of human iPS, eliminating aging inflammation due to somatic cell waste, producing an oral drug of T cells of the iPS by coating them or putting them in a protein "cage", and making a version 4 of an oral drug for eternal youth and immortality.
机译:要解决的问题:通过制造用于永恒和永生的药物的改进版本4并应用最新科学技术来完善永恒和永生;解决方案:通过T细胞再分化的作用扩展端粒来实现永恒和永生。的人类iPS,消除了因体细胞废物引起的衰老炎症,通过将iPS的T细胞包衣或将它们放入蛋白质“笼子”中来生产口服TPS药物,并制成了用于永生和永生的第四版口服药物。

著录项

  • 公开/公告号JP2013151554A

    专利类型

  • 公开/公告日2013-08-08

    原文格式PDF

  • 申请/专利权人 KAJISA ISAO;

    申请/专利号JP20130086924

  • 发明设计人 KAJISA ISAO;

    申请日2013-04-01

  • 分类号A61K35/14;A61P29;C12N5/10;

  • 国家 JP

  • 入库时间 2022-08-21 17:00:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号